Please login to the form below
The Lancet
This page shows the latest The Lancet news and features for those working in and with pharma, biotech and healthcare.
AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
Data from one real-world study, published as a pre-print on The Lancet server, contained analysis from over one million people assessing the incidence rates of the blood clotting disorders ... However, the rate jumped to 8.1 million vaccinees after the
Latest news
-
AZ licenses pneumonia mAb to Aridis Pharmaceuticals for $11m upfront
The candidate – suvratoxumab – is ready for phase 3 clinical evaluation for the prevention of pneumonia. ... Previous data, published in the Lancet Infectious Diseases in June, suggested that the mAb was not effective at reducing pneumonia caused by
-
Oxford University’s malaria vaccine is 77% effective
Results from a phase 2b trial of the vaccine candidate – R21/Matrix-M – have been published on SSRN/Preprints with The Lancet. ... No serious adverse events related to the vaccine were observed, the researchers noted.
-
Germany backs use of AZ/Oxford COVID-19 vaccine in over-65s
weeks. This recommendation was based on a study that showed that extending the time between doses improves the efficacy of the vaccine. ... The data, published in a preprint with The Lancet, reported that ‘vaccine efficacy was higher, after the second
-
EMA begins rolling review process for Sputnik V COVID-19 vaccine
Late-stage trial results published in The Lancet found that the vaccine was 91.6% effective at protecting against COVID-19. ... We welcome the start of the rolling review procedure by EMA of Sputnik V.
-
AZ/Oxford University’s COVID-19 vaccine to be evaluated in children and young adults
The study, which launched last Friday, will begin the first vaccinations in February. ... New data, published in a preprint with The Lancet, reported that the efficacy of the ChAdOx1 nCoV-19 vaccine was higher after the second dose in those with a dosing
AZ licenses pneumonia mAb to Aridis Pharmaceuticals for $11m upfront
Oxford University’s malaria vaccine is 77% effective
Germany backs use of AZ/Oxford COVID-19 vaccine in over-65s
EMA begins rolling review process for Sputnik V COVID-19 vaccine
More from news
Approximately 2 fully matching, plus 139 partially matching documents found.
Latest Intelligence
-
Alzheimer’s: the search for a cure
In closing, a 2020 report by the Lancet Commission identified 12 lifestyle-related risk factors for dementia. ... By seeking help and making simple lifestyle changes, we can delay the onset of dementia by 40%, according to the Lancet Commission report.
-
The search for effective drug treatments for COVID-19
In the context of a global pandemic, this timeline was reduced to months. ... They were coordinated by the China-Japan Friendship Hospital in Beijing. The results from the severe study was published in The Lancet.
-
Rethinking our approach to infectious disease preparedness
We’re not ready’. Gates said: “Today, the greatest risk of global catastrophe. ... According to a paper in The Lancet, early research has found that nearly 15% of all COVID-19 patients acquire deadly secondary bacterial infections.
-
How will COVID-19 affect uptake of vaccinations against other diseases?
Will COVID-19 help or hinder the quest to increase uptake of other vaccinations? ... Recent controversies surrounding the release of data on promising COVID-19 therapies in press releases prior to publication of detailed trial results, and the retraction
-
Industry needs an aligned position on the future of the EU OMP Regulation
In 2017, two serving Dutch ministers wrote in The Lancet that ‘the system is broken… companies can ask the price they like’. ... If the OMP Regulation is reopened, we may see a new law proposed by 2021.
Alzheimer’s: the search for a cure
The search for effective drug treatments for COVID-19
Rethinking our approach to infectious disease preparedness
How will COVID-19 affect uptake of vaccinations against other diseases?
Industry needs an aligned position on the future of the EU OMP Regulation
More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.
Latest appointments
-
Sudler London makes three senior hires
Boulding joins with more than 25 years of experience in the pharma industry, having worked in sales and marketing prior to moving into senior client roles in healthcare advertising agencies. . ... Pound, too, has significant medical communications and
-
ROCK names new managing director
His experience prior to Pollen includes the role of managing director for Cohn &Wolfe's healthcare business and senior business director at Ogilvy Healthworld. ... He also has experience at publishing firms The Lancet and Medpress.
Sudler London makes three senior hires
ROCK names new managing director
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Addressing Climate Impact: The Healthcare Paradox
Observable effects of climate change are already being felt – for example, the Lancet’s 2019 report on the infection rates of dengue fever (expressed as vectorial capacity for transmissions) showed that ... In 2015 the global pharmaceutical industry
-
Fake News is Bad for your Health
Trust in vaccines fell as a result of emotional contagion, triggered by the 1998 publication of Andrew Wakefield's paper in the Lancet linking the MMR vaccine with autism and bowel ... But the majority of the public don't even read the mainstream media.
-
World Diabetes Day: Interaction and impact of diabetes on mental health
16. Snoek, F.J., Bremmer, M.A. and Hermanns, N., 2015. Constructs of depression and distress in diabetes: time for an appraisal. The Lancet Diabetes &Endocrinology, 3(6), pp.450-460. ... 22. Diabetes UK (2017) The Future of Diabetes
-
Focus on multiple myeloma treatment: Witnessing a transformation
opening of a recent editorial in the Lancet on multiple myeloma. ... This meant significant cost in terms of toxicity, and marginal impact on the overall survival of patients. .
-
Exploring MINT: Part 4 - Turkey
Public sector healthcare reforms. Turkey’s implementation of universal healthcare coverage has received considerable global acclaim. Notably in 2013, an article was published in the Lancet hailing the success of the ... The government has actively
Addressing Climate Impact: The Healthcare Paradox
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
CEO Pricing & Market Access, UK
-
Six figure salary
-
Senior Account Manager
-
Competitive salary offered
-
Omnichannel Strategy Consultant
-
Competitive Salary
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Biosimilars boosted by FDA's landmark ruling for Boehringer’s Cyltezo
- US demand for COVID-19 antibody treatments rising fast
- EU “still interested” in Valneva COVID vaccine despite UK snub
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Biogen's ALS drug tofersen misses phase 3 endpoint
- Unlocking the Potential of Electronic Medical Records Using Artificial Intelligence
- Valneva COVID-19 vaccine more effective than AZ
- Real-world data highlights flu vaccine efficacy
- Biosimilars boosted by FDA's landmark ruling for Boehringer’s Cyltezo
- Vertex moves ahead with its bid to develop a curative treatment for type 1 diabetes
- Best practice in UK diabetes care recognised at prestigious national awards
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Beyond yoga and smoothies – providing real support for employee well-being
- The Future of eHealth: Contactless Health Monitoring
- How do you define a biotech company?
- Attracting the best talent to build Lucid’s future
- Engaging HCPs on their own terms: how pharma can adapt to the post-pandemic digital era
PMHub
Fishawack Health
Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in...
Latest intelligence
- Breaking the silence: It’s time to talk about the menopause
- Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
- Committing time to making meaningful connections - top 5 tips
- Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
- News:
- Senior Analytics Specialist joins Research Partnership...
